Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-16.24%
↑ 70% above average
Average (9y)
-54.52%
Historical baseline
Range
High:-16.24%
Low:-106.15%
CAGR
-11.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -16.24% | +45.1% |
| 2023 | -29.60% | -47.7% |
| 2022 | -20.04% | +68.1% |
| 2021 | -62.72% | +24.3% |
| 2020 | -82.80% | -106.2% |
| 2019 | -40.16% | +62.2% |
| 2018 | -106.15% | -27.5% |
| 2017 | -83.25% | -46.4% |
| 2016 | -56.86% | -20.0% |
| 2015 | -47.38% | - |